Velocity Pharmaceutical Development
Pharmaceuticals, South San Francisco, California, United States, 1-10 Employees
Phone Number: +19*********
Who is VELOCITY PHARMACEUTICAL DEVELOPMENT
VPDs strategy is to create, invest in, and manage a portfolio of project-focused companies, each of which contains a single drug candidate acquired from a third party. VPD designs and exe...
Read More
-
Headquarters: South San Francisco, California, United States
-
Date Founded: 2011
-
Employees: 1-10
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 5912
|
NAICS Code: 456110 |
Show More
Does something look wrong? Fix it. | View contact records from VELOCITY PHARMACEUTICAL DEVELOPMENT
Velocity Pharmaceutical Development Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Velocity Pharmaceutical Development
Answer: Velocity Pharmaceutical Development's headquarters are located at South San Francisco, California, United States
Answer: Velocity Pharmaceutical Development's phone number is +19*********
Answer: Velocity Pharmaceutical Development's official website is https://vpd.net
Answer: Velocity Pharmaceutical Development's revenue is $25 Million to $50 Million
Answer: Velocity Pharmaceutical Development's SIC: 5912
Answer: Velocity Pharmaceutical Development's NAICS: 456110
Answer: Velocity Pharmaceutical Development has 1-10 employees
Answer: Velocity Pharmaceutical Development is in Pharmaceuticals
Answer: Velocity Pharmaceutical Development contact info: Phone number: +19********* Website: https://vpd.net
Answer: VPDs strategy is to create, invest in, and manage a portfolio of project-focused companies, each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates. VPD acquires rights to individual therapeutic drug candidates from biotechnology companies, pharmaceutical companies and academia, and invests in their development through clinical proof-of-concept (generally demonstration of human safety and efficacy in phase 2a trials). Following proof-of-concept, VPD seeks to sell each drug asset to a major pharmaceutical company. There is a robust demand by pharmaceutical acquirers for products with key human clinical data. Our model provides partners with a compelling alternative strategy for the development of their drug candidates. By partnering with VPD, the owner of a drug candidate can achieve the funding needed to take the drug candidate to clinical proof-of-concept while accessing a world-class team to design and oversee the development program. The contributor of the drug candidate receives equity in the company created to house its drug program and benefits from the ultimate financial upside upon clinical success and sale of that company to a pharmaceutical company. The Velocity model is much more efficient than traditional company-based drug development because it avoids the cost and time of building a separate management team and infrastructure around each program.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month